What is Certara, Inc. (CERT)?
Certara, Inc. is a global biosimulation company that provides software and services to optimize drug development and improve regulatory decision-making. The company leverages modeling and simulation technologies to support pharmaceutical and biotechnology companies in the design, development, and approval of new therapies. Certara's offerings include platforms for pharmacokinetics, pharmacodynamics, and quantitative systems pharmacology, which help in predicting drug behavior and efficacy. The company also provides consulting services that assist clients in regulatory submissions and clinical trial design. Certara operates in various sectors including oncology, infectious diseases, and rare diseases. Its solutions are utilized by researchers, clinicians, and regulatory agencies to enhance the efficiency and success rate of drug development processes. The company emphasizes scientific innovation and data-driven approaches to address challenges in the pharmaceutical industry. Certara's global presence includes offices and collaborations across North America, Europe, and Asia, supporting a diverse client base in the life sciences sector.
Certara, Inc. Stock Price Today: Live Overview
The price today is shaped by current intraday fluctuations with Certara, Inc. priced at $6.57. It has experienced a trading range between $6.49 and $6.63, reflecting a daily change of -0.7587%.
FAQ: Certara, Inc. (CERT)
What is the current price of CERT stock?
The current price is $6.57.
Does CERT pay dividends?
Certara, Inc. does not currently distribute dividends.
Does CERT have a formal corporate presence or regional headquarters in the UAE?
Certara, Inc. maintains a regional presence in Dubai Internet City, UAE.
What is CERT best known for?
Certara, Inc. is most famous for its drug development software and consulting services.
What assets are typically shown together with CERT?
Commonly shown alongside CERT: ServiceTitan, Inc., Sea Limited, WM Technology Inc
Latest shares articles



